Loretta Sue Parton, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 127 W Meeting St, Dandridge, TN 37725 Phone: 865-397-6680 Fax: 865-397-6681 |
Ms. Barbara Acker Brock, FNP,MSN,IBCLC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 931 Industrial Park Rd, Suite 200, Dandridge, TN 37725 Phone: 865-397-3930 |
Kelley Coffey, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1237 Gay St, Dandridge, TN 37725 Phone: 865-712-8204 |
Amanda Jeanette Thore, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 150 W Price Rd, Dandridge, TN 37725 Phone: 865-475-6161 Fax: 865-475-9857 |
Kristin Leann Belcher, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 127 W Meeting St, Dandridge, TN 37725 Phone: 865-397-6680 Fax: 865-397-6681 |
Mrs. Kendal Wells Holbrook, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 150 W Price Rd, Dandridge, TN 37725 Phone: 865-475-6161 Fax: 865-475-9857 |
News Archive
A major study of Medicare beneficiaries shows that the risk of hip fractures was significantly reduced in patients who had had cataract surgery, compared to patients who did not undergo the procedure. Published in the August edition of the Journal of the American Medical Association (JAMA) the researchers believe their study is the first to demonstrate that cataract surgery reduces the rate of fractures in older patients with vision loss.
Although botulinum toxin A injections are U.S. Food and Drug Administration approved for preventive treatment for chronic migraines, a review and analysis of previous studies finds a small to modest benefit for patients with chronic migraine headaches and chronic daily headaches, although botox injections were not associated with greater benefit than placebo for preventing episodic migraine or chronic tension-type headaches, according to an article in the April 25 issue of JAMA.
Cenestra Health announced today that the U.S. Patent and Trademark Office has issued a key patent related to the company's high-purity omega-3 fatty acid formulations and their methods of use. U.S. Patent No. 7652068, entitled "Omega-3 Fatty Acid Formulations," covers a unique, high-purity formulation of the omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid).
There has been a lot of information about the importance of taking preventative measures against H1N1, primarily through vaccination. But what if a person has already contracted H1N1? What if that person is a young child?
› Verified 7 days ago